학술논문

Efficacy and safety of tirzepatide versus semaglutide once weekly as add-on therapy to metformin in people with type 2 diabetes (SURPASS-2)
Document Type
Journal
Source
DIABETOLOGIA; SEP 2021, 64 SUPPL 1, p14-p15, 2p. Supplement: 1
Subject
Language
English
ISSN
14320428